Clinical Trial Update: ONC201 in Pediatric H3 K27M Gliomas [Phase 1]

View source ↗

Summary

Phase 1 trial update of ONC201 in pediatric H3 K27M gliomas including Diffuse Intrinsic Pontine Glioma and malignant glioma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Malignant Glioma

Drugs mentioned

• ONC201 (ONC201)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Diffuse Intrinsic Pontine Glioma, Glioma, Malignant | Phase 1 | Status: TERMINATED